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Objectives and study
A 4- year-old boy was admitted to our hospital because
of progressive proximal muscular weakness of 4 weeks
duration, heliotrope rash, erythematous skin lesions in
the trunk and limbs and febrile fever. The muscle
enzymes were elevated: creatine kinase 7,056 IU/L (0–
170), aldolase 40.3 U/L (0–8), aspartate transaminase 601
U/L (10–37), alanine transaminase 289 U/L (10–37). The
laboratory test revealed a hemoglobin level of 86 g/dL, a
platelet count of 100,000/mm3, an erythrocyte sedimen-
tation rate of 30 mm/h . A peripheral blood smear
revealed schistocytes (2%). Urine analysis revealed large
number of red blood cells and proteinuria 1.06 grams /
liter. The level of total serum bilirubin was 37 µmol / l
(normal up to 17 µmol / l). Serum creatinine was 200
µmol/l. Direct and indirect Coombs’ reaction was nega-
tive. Prothrombin and thrombin time and D-dimers were
within normal limits.The serologic tests for the antinuc-
lear antibody, antineutrophil cytoplasmic antibody, anti-
bodies to DNA, cardiolipin antibodies, antibodies to b2-
glycoproteins were negative. Lupus anticoagulant was not
detected. The electromyographic findings were consistent
with the inflammatory myopathy. A renal biopsy con-
tained 43 glomeruli and was evaluated by light and
immunofluorescence microscopies. Diffuse fibrin-platelet
thrombi were revealed in glomerular capillaries. Small
arteries was narrowed by the swelling of the endothelium.
The expression of the fibrin + +. There were no immune
deposits at any location.
Methods
The patient received three pulses of methylprednisolone
30mg /kg daily, followed by oral prednisolone 60 mg/
day. Alternate-day plasmapheresis with fresh frozen
plasma for 1 week and intravenous cyclophosphamide
treatment (750 mg/m
2/month) were started.
Results
The treatment resulted in slow improvement in his
muscle weakness within 4 weeks along with markedly
decreased muscle enzymes and normalization of renal
function. Prednisolone was changed to 1 mg/day of oral
prednisolone, which was later decreased to 0.5 mg/day
followed by transition to long-term oral methotrexate
10 mg / m2/week (after 6 monthly pulses of
cyclophosphamide).
Conclusions
The described clinical case demonstrates the varied nat-
ure of renal pathology at juvenile dermatomyositis. The
kidney damage appeared to have been very severe. But
under the well-timed and adequate therapy it underwent
to a back development in a great degree.
Author details
1Department of Pediatric Rheumatology, Orenburg Regional Children’s
Hospital, Orenburg, Russia.
2Department of Pediatric Nephrology, Orenburg
Regional Children’s Hospital, Orenburg, Russia.
Published: 14 September 2011
doi:10.1186/1546-0096-9-S1-P49
Cite this article as: Frolenko et al.: Thrombotic microangiopathy in
juvenile dermatomyositis. Pediatric Rheumatology 2011 9(Suppl 1):P49.
* Correspondence: annafr@mail.ru
1Department of Pediatric Rheumatology, Orenburg Regional Children’s
Hospital, Orenburg, Russia
Full list of author information is available at the end of the article
Frolenko et al. Pediatric Rheumatology 2011, 9(Suppl 1):P49
http://www.ped-rheum.com/content/9/S1/P49
© 2011 Frolenko et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.